ANI. The SEC meeting in this regard will start at 12 pm on today. The meeting comes in the wake of Serum Institute of India (SII) filing an application with the Drugs Controller General of India (DCGI) regarding approval for a booster dose of Covishield.
The Serum Institute cites that there is adequate stock of the Covid vaccine in the country now and a demand for a booster shot is there due to the emergence of new coronavirus variant, Omicron.
The Serum Institute is the first vaccine manufacturing company in India to apply for approval for Covishield as a booster dose.
Many experts have also recommended booster doses in India especially after the emergence of new highly transmissible COVID-19 variant Omicron.